29.10.2012 - Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio
29 Oct 2012
29.10.2012 Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio
© Shionogi B.V. 2019. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Kingsfordweg 151, 1043GR, Amsterdam, the Netherlands.
Report Side Effect
Just to let you know, you are now moving to another website this is not under our control and Shionogi B.V. is not responsible for its contents.